RecruitingNot ApplicableNCT07542184

Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Panama

A First in Human (FIH) Early Feasibility Study (EFS) to Evaluate the Safety and Performance of the Nanochon Chondrograft™ Implant for Re-surfacing of Cartilage Lesions

Sponsor

Nanochon, Inc.

Enrollment

5 participants

Start Date

Jul 30, 2026

Study Type

INTERVENTIONAL

Conditions

Knee Cartilage Lesions

Summary

The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.

Eligibility

Min Age: 22 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Nanochon Chondrograft for people with knee cartilage lesions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 22 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.